367 related articles for article (PubMed ID: 17472698)
61. Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
Riddle JL; Rokosik SL; Napier TC
Behav Brain Res; 2012 Jul; 233(1):15-23. PubMed ID: 22727039
[TBL] [Abstract][Full Text] [Related]
62. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
[TBL] [Abstract][Full Text] [Related]
63. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats.
Shoblock JR; Sullivan EB; Maisonneuve IM; Glick SD
Psychopharmacology (Berl); 2003 Feb; 165(4):359-69. PubMed ID: 12491026
[TBL] [Abstract][Full Text] [Related]
64. Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring.
Naef L; Moquin L; Dal Bo G; Giros B; Gratton A; Walker CD
Neuroscience; 2011 Mar; 176():225-36. PubMed ID: 21187125
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of Wnt signalling dose-dependently impairs the acquisition and expression of amphetamine-induced conditioned place preference.
Islam F; Xu K; Beninger RJ
Behav Brain Res; 2017 May; 326():217-225. PubMed ID: 28284949
[TBL] [Abstract][Full Text] [Related]
66. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
[TBL] [Abstract][Full Text] [Related]
67. Phentermine induces conditioned rewarding effects via activation of the PI3K/Akt signaling pathway in the nucleus accumbens.
Hong SI; Kim MJ; You IJ; Kwon SH; Ma SX; Hwang JY; Seo JY; Ko YH; Lee BR; Lee SY; Jang CG
Psychopharmacology (Berl); 2016 Apr; 233(8):1405-13. PubMed ID: 26887589
[TBL] [Abstract][Full Text] [Related]
68. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.
Hedges DM; Obray JD; Yorgason JT; Jang EY; Weerasekara VK; Uys JD; Bellinger FP; Steffensen SC
Neuropsychopharmacology; 2018 May; 43(6):1405-1414. PubMed ID: 29185481
[TBL] [Abstract][Full Text] [Related]
69. Gabapentin blocks methamphetamine-induced sensitization and conditioned place preference via inhibition of α₂/δ-1 subunits of the voltage-gated calcium channels.
Kurokawa K; Shibasaki M; Mizuno K; Ohkuma S
Neuroscience; 2011 Mar; 176():328-35. PubMed ID: 21182903
[TBL] [Abstract][Full Text] [Related]
70. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
Nagai T; Takuma K; Nabeshima T; Yamada K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
[TBL] [Abstract][Full Text] [Related]
71. Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.
Zhu J; Chen Y; Zhao N; Cao G; Dang Y; Han W; Xu M; Chen T
J Neurosci Res; 2012 Apr; 90(4):895-904. PubMed ID: 22420045
[TBL] [Abstract][Full Text] [Related]
72. BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms.
Ren Q; Ma M; Yang C; Zhang JC; Yao W; Hashimoto K
Transl Psychiatry; 2015 Oct; 5(10):e666. PubMed ID: 26506052
[TBL] [Abstract][Full Text] [Related]
73. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
Chiang YC; Chen JC
J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
[TBL] [Abstract][Full Text] [Related]
74. Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function.
Escobar AP; Cornejo FA; Olivares-Costa M; González M; Fuentealba JA; Gysling K; España RA; Andrés ME
J Neurochem; 2015 Sep; 134(6):1081-90. PubMed ID: 26112331
[TBL] [Abstract][Full Text] [Related]
75. Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization.
Yang PP; Huang EY; Yeh GC; Tao PL
J Biomed Sci; 2006 Sep; 13(5):695-702. PubMed ID: 16865411
[TBL] [Abstract][Full Text] [Related]
76. Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.
Loewinger GC; Beckert MV; Tejeda HA; Cheer JF
Neuropharmacology; 2012 Jun; 62(7):2192-201. PubMed ID: 22306525
[TBL] [Abstract][Full Text] [Related]
77. Antipsychotic treatment leading to dopamine supersensitivity persistently alters nucleus accumbens function.
El Hage C; Bédard AM; Samaha AN
Neuropharmacology; 2015 Dec; 99():715-25. PubMed ID: 25823912
[TBL] [Abstract][Full Text] [Related]
78. Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice.
Tatsuta T; Kitanaka N; Kitanaka J; Morita Y; Takemura M
Pharmacol Biochem Behav; 2007 May; 87(1):48-55. PubMed ID: 17482247
[TBL] [Abstract][Full Text] [Related]
79. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
[TBL] [Abstract][Full Text] [Related]
80. L-isocorypalmine reduces behavioral sensitization and rewarding effects of cocaine in mice by acting on dopamine receptors.
Xu W; Wang Y; Ma Z; Chiu YT; Huang P; Rasakham K; Unterwald E; Lee DY; Liu-Chen LY
Drug Alcohol Depend; 2013 Dec; 133(2):693-703. PubMed ID: 24080315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
